| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/08/2009 | CN100475847C Synthesis process for analogue 2R-515 of juvenile hormone |
| 04/08/2009 | CN100475846C Improved secretion of neublastin |
| 04/08/2009 | CN100475845C Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 04/08/2009 | CN100475844C Corticotropin releasing factor receptor 2 agonists |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475842C Molecular structure of RHD negative genes locus |
| 04/08/2009 | CN100475841C Process for preparing placental polypeptide for injection |
| 04/08/2009 | CN100475840C Wasp antibiotic peptide and preparing method and use thereof |
| 04/08/2009 | CN100475271C Somatostatin analogs with inhibitory activity to growth hormone release |
| 04/07/2009 | US7514599 Protein kinase stress-related proteins and methods of use in plants |
| 04/07/2009 | US7514598 Preparing plants with enhanced invertase inhibition for use in generating seeds with increased reserves; tissue engineering |
| 04/07/2009 | US7514594 Somatic and/or germ cells comprising a nucleic acid with promoter capable of directing protein expression; use in treating, diagnosing and preventing osteoporosis |
| 04/07/2009 | US7514593 Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
| 04/07/2009 | US7514592 transgenic rodents genetically engineered to knock out gene expression of active scavenger receptor class BI (SR-BI) and having apolipoprotein E activity or expression decreased to 2-5% of normal levels; models of cardiovascular disoders induced by feeding a lipid enriched diet |
| 04/07/2009 | US7514547 Helicobacter felis vaccine |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514538 Compositions and methods for the diagnosis and treatment of tumor |
| 04/07/2009 | US7514537 Chimeric immunoreceptor useful in treating human gliomas |
| 04/07/2009 | US7514536 interleukins produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; polypeptide has anti-hepatitis C activity |
| 04/07/2009 | US7514535 Chimeric immunogens |
| 04/07/2009 | US7514534 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 04/07/2009 | US7514533 polypeptides and the nucleotide sequence from the encoding gene, used in the diagnosis, prevention, and treatment of diseases |
| 04/07/2009 | US7514532 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors |
| 04/07/2009 | US7514407 Racemic mixture of proteins |
| 04/07/2009 | US7514405 Method involves administering a therapeutically effective amount of Serp-1, its analogs, and biologically active fragments thereof in combination with an anti-rejection agent, such as cyclosporin, and a pharmaceutically acceptable |
| 04/07/2009 | US7514403 Process for the stabilization of proteins in an aqueous solution comprising cysteine in a concentration between 150 and 220mM |
| 04/07/2009 | US7514402 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 04/07/2009 | US7514401 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 04/07/2009 | US7514400 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 04/07/2009 | US7514399 Use in tissue bonding and protein cross-linking and use in tissue and arterial repair, preservation of expanded internal luminal diameters, and local delivery of drugs, skin care materials, sunscreens, and cosmetics |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514261 Platelet-derived growth factor protection of cardiac myocardium |
| 04/07/2009 | US7514257 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation |
| 04/07/2009 | US7514252 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 04/07/2009 | US7514240 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514238 Growth factor homolog zvegf4 |
| 04/07/2009 | US7514233 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514224 Arrays of PDZ domain polypeptides |
| 04/07/2009 | US7514208 Methods for identifying modulators of cyclic nucleotide-gated cation channels |
| 04/07/2009 | US7514090 Monocyte locomotion inhibitory factor |
| 04/07/2009 | US7514089 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514084 isolated nonapeptide that bind to an human leukocyte antigen (HLA-A 0201) restricted T cell receptors with high affinity and induce a high cytotoxic T lymphocyte response, used for treating or preventing tumors and cancers |
| 04/07/2009 | US7514083 Protein allergens of the species cynodon dactylon |
| 04/07/2009 | US7514082 Virus suppressing factor (VSF) for use in treatment and prevention of viral infection in animal and humans |
| 04/07/2009 | US7514081 administering an isolated antibody or an antigen-binding fragment that binds a novel member of the tumor necrosis factor (TNF) family of cytokines, to inhibit TNF- alpha induction |
| 04/07/2009 | US7514077 administering an antibody that binds Interleukins, to neurons, for the treatment of inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues; antiinflammatory agents; analgesics |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2420058C Cyclic peptides having melanocortin-4 receptor agonist activity |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2387440C Regulatory region of a lipid transfer protein (ltpw1) from aleurone tissue of wheat |
| 04/07/2009 | CA2341355C Procedure for the chromatographic purification of insulins |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2311643C Compositions and methods for inducing gene expression |
| 04/07/2009 | CA2306447C Purification of molecules |
| 04/07/2009 | CA2294575C Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 04/07/2009 | CA2290883C Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2268386C High molecular weight trichoderma cellulase |
| 04/07/2009 | CA2265801C Method and apparatus for analyzing images |
| 04/07/2009 | CA2264488C A method for generating birnavirus from synthetic rna transcripts |
| 04/07/2009 | CA2220447C Novel fusion protein recovery and purification methods |
| 04/07/2009 | CA2206343C Reagents and processes for targeting mutant epidermal growth factor receptors |
| 04/07/2009 | CA2205914C Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2151883C Synthetic tropoelastin |
| 04/07/2009 | CA2127262C Somatostatin receptors |
| 04/07/2009 | CA2117492C Bystander suppression of autoimmune diseases |
| 04/07/2009 | CA2102115C In vitro methods for determining in vivo thrombotic events |
| 04/07/2009 | CA2100472C Inherited and somatic mutations of apc gene in colerectal cancer of humans |
| 04/02/2009 | WO2009042998A1 Quinoa protein concentrate, production and functionality |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042922A2 Peptide-peptidase inhibitor conjugates and methods of making and using same |
| 04/02/2009 | WO2009042910A2 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 04/02/2009 | WO2009042794A2 Venezuelan equine encephalitis replicons expressing paramyxovirus glycoproteins as vaccine |
| 04/02/2009 | WO2009042753A1 Bs3 resistance gene and methods of use |
| 04/02/2009 | WO2009042742A1 Dlx1 cancer markers |
| 04/02/2009 | WO2009042570A2 Modified t cell receptors and related materials and methods |
| 04/02/2009 | WO2009042565A2 Inhibitors of eppin/semenogelin binding as male contraceptives |
| 04/02/2009 | WO2009042538A2 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon |
| 04/02/2009 | WO2009042194A2 Methods of synthesis for therapeuthic anti-hiv peptides |
| 04/02/2009 | WO2009042162A2 Compositions and methods for inhibiting interleukin pathways |
| 04/02/2009 | WO2009041902A1 Prion protein derived cell penetrating peptides and their uses |
| 04/02/2009 | WO2009041858A1 METHOD FOR PRODUCING HUMAN PROINSULIN RECOMBINANT c-PEPTIDE |
| 04/02/2009 | WO2009041831A1 PHAGE ϕMRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
| 04/02/2009 | WO2009041733A1 Receptor mutant, and method for detection of factor associated with lifestyle-related disease using the same |
| 04/02/2009 | WO2009041501A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | WO2009041026A1 Cxcl10 production inhibitor |
| 04/02/2009 | WO2009040726A2 Rhamnose antagonists and use thereof |
| 04/02/2009 | WO2009040674A2 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 04/02/2009 | WO2009040543A2 Bioactive peptide |
| 04/02/2009 | WO2009040529A1 Bacterial vaccine |
| 04/02/2009 | WO2009040363A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 04/02/2009 | WO2009040338A1 Designed armadillo repeat proteins |
| 04/02/2009 | WO2009040319A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |